These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19286195)

  • 61. Frontal assessment battery and brain perfusion imaging in early dementia.
    Yoshida H; Terada S; Sato S; Kishimoto Y; Ata T; Ohshima E; Honda H; Ishihara T; Kuroda S
    Dement Geriatr Cogn Disord; 2009; 27(2):133-8. PubMed ID: 19182480
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Noninvasive quantification of cerebral blood flow using 99mTc-ECD and SPECT.
    Odano I; Ohkubo M; Yokoi T
    J Nucl Med; 1999 Oct; 40(10):1737-44. PubMed ID: 10520717
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Cognitive function, cerebral blood flow and brain atrophy in olivo-ponto-cerebellar atrophy].
    Kobayashi S; Murata A; Yamaguchi S; Kitani M; Okada K
    Rinsho Shinkeigaku; 1990 Feb; 30(2):157-63. PubMed ID: 2350927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Early effects of treatment on regional cerebral blood flow in first episode schizophrenia patients evaluated with 99Tc-ECD-SPECT.
    Novak B; Milcinski M; Grmek M; Kocmur M
    Neuro Endocrinol Lett; 2005 Dec; 26(6):685-9. PubMed ID: 16380684
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
    Ijiro T; Yaguchi A; Yokoyama A; Abe Y; Kiguchi S
    Eur J Pharmacol; 2020 Sep; 882():173271. PubMed ID: 32534077
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Remote regional cerebral blood flow consequences of focused infarcts of the medulla, pons and cerebellum.
    Rousseaux M; Steinling M
    J Nucl Med; 1999 May; 40(5):721-9. PubMed ID: 10319742
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease.
    Imon Y; Matsuda H; Ogawa M; Kogure D; Sunohara N
    J Nucl Med; 1999 Oct; 40(10):1583-9. PubMed ID: 10520695
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Postoperative changes in SPECT-rCBF in hydrocephalus.
    Piechnik SK; Hultin L
    Acta Neurochir Suppl; 2005; 95():169-72. PubMed ID: 16463844
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of the benzodiazepine antagonist flumazenil on regional cerebral blood flow in human volunteers.
    Wolf J; Friberg L; Jensen J; Hansen PB; Andersen AR; Lassen NA
    Acta Anaesthesiol Scand; 1990 Nov; 34(8):628-31. PubMed ID: 2125793
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration.
    Mori M; Adachi Y; Mori N; Kurihara S; Kashiwaya Y; Kusumi M; Takeshima T; Nakashima K
    J Neurol Sci; 2002 Mar; 195(2):149-52. PubMed ID: 11897246
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Local cerebral blood flow in motor neuron disease: correlation with clinical findings.
    Kobari M; Obara K; Watanabe S; Dembo T; Fukuuchi Y
    J Neurol Sci; 1996 Dec; 144(1-2):64-9. PubMed ID: 8994105
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mapping cerebral blood flow during speech production in hereditary ataxia.
    Sidtis JJ; Gomez C; Groshong A; Strother SC; Rottenberg DA
    Neuroimage; 2006 May; 31(1):246-54. PubMed ID: 16443374
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contribution of cholinergic vasodilators on the increase in cerebral cortical blood flow responses to the intravenous administration of thyrotropin releasing hormone in anesthetized rats.
    Inanami O; Meguro K; Ohno K; Sato A
    Neurosci Lett; 1988 May; 88(2):184-8. PubMed ID: 2967928
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission.
    Ijiro T; Yaguchi A; Yokoyama A; Kiguchi S
    Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):950-958. PubMed ID: 35637550
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Delayed administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, improves cerebral blood flow and metabolism in rat postischaemic brain.
    Katsumata T; Katayama Y; Yonemori H; Muramatsu H; Otori T; Nishiyama Y; Yamada H; Nakamura H; Terashi A
    Clin Exp Pharmacol Physiol; 2001; 28(1-2):48-54. PubMed ID: 11153536
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Motor disabilities and effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
    Kimura I; Ohtomo H; Kogure K
    Tohoku J Exp Med; 1983 Apr; 139(4):331-7. PubMed ID: 6408760
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone.
    Faden AI; Hallenbeck JM; Brown CQ
    Neurology; 1982 Oct; 32(10):1083-7. PubMed ID: 6811967
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of thyrotropin-releasing hormone on regional cerebral blood flow in man.
    Oturai PS; Friberg L; Sam I; Perrild H
    Acta Endocrinol (Copenh); 1992 Mar; 126(3):243-6. PubMed ID: 1574953
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Successful treatment of progressive myoclonus epilepsy with TRH.
    Tanaka C; Maegaki Y; Koeda T; Ohta S; Takeshita K
    Pediatr Neurol; 1998 May; 18(5):442-4. PubMed ID: 9650689
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Spinocerebellar degeneration and neuropeptides.
    Matsuoka Y; Sakurai N
    Jpn J Med; 1989; 28(6):791-3. PubMed ID: 2517445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.